Health · 23 June 2026

Type 1 diabetes drug delays onset by three years

This is the first treatment of its kind, offering people up to three extra years before needing daily insulin for type 1 diabetes. NICE, the health guidance body, approved teplizumab for children aged eight and over and adults with early-stage disease. Around 1,100 people could be eligible in the first year for the 14-day course.

By BriefTea Editorial · 23 June 2026 at 7:24

Reported by BBC · How we write briefs

Get the app

Understand this story

What is Type 2 diabetes?

More briefs

HealthGreat Ormond Street's Same-Day Test Finds Hidden Infections in Sick Children HealthImmune cell found to kill small cell lung cancer in lab tests HealthDiabetics sleeping 8+ hours face nearly double kidney disease risk HealthNo perfect age to start HRT, but benefits peak before 60, experts say HealthOver 12,000 fake weight-loss pens worth £2m seized in Birmingham raid HealthTrans patients in England to go on wards matching birth sex More health stories → Browse all stories →